TXMD

TherapeuticsMD, Inc. (NASDAQ:TXMD) is a women's healthcare company founded in 2008 and headquartered in Boca Raton, Florida. The company went public in 2007 and specializes in developing and commercializing prescription pharmaceutical products specifically designed for women's health needs. After experiencing significant revenue growth in earlier years, the company has undergone substantial restructuring, including asset divestitures and debt reduction, and currently operates with a much smaller revenue base focused on its core women's health products.